Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126253282 | 12625328 | 2 | F | 20160809 | 20160805 | 20160822 | EXP | TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-121453 | RANBAXY | 74.00 | YR | F | Y | 0.00000 | 20160822 | OT | GB | TR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126253282 | 12625328 | 1 | PS | LITHIUM. | LITHIUM | 1 | Oral | 300 MG, TID | Y | U | 91027 | 300 | MG | Q8H | |||||
| 126253282 | 12625328 | 2 | I | QUETIAPINE. | QUETIAPINE | 1 | Unknown | 400 MG, DAILY | Y | U | 0 | 400 | MG | ||||||
| 126253282 | 12625328 | 3 | I | Valsartan/Hydrochlorothiazide | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | Unknown | 160 MG/ 25 MG ONCE DAILY | Y | U | 0 | ||||||||
| 126253282 | 12625328 | 4 | C | LEVODOPA/CARBIDOPA 250/25 | 2 | Unknown | 1 DF, BID | Y | U | 0 | 1 | DF | Q12H |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126253282 | 12625328 | 1 | Product used for unknown indication |
| 126253282 | 12625328 | 2 | Product used for unknown indication |
| 126253282 | 12625328 | 3 | Product used for unknown indication |
| 126253282 | 12625328 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126253282 | 12625328 | HO |
| 126253282 | 12625328 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126253282 | 12625328 | Blood pressure increased | |
| 126253282 | 12625328 | Coma scale abnormal | |
| 126253282 | 12625328 | Confusional state | |
| 126253282 | 12625328 | Drug interaction | |
| 126253282 | 12625328 | Mental disorder | |
| 126253282 | 12625328 | Muscle rigidity | |
| 126253282 | 12625328 | Nausea | |
| 126253282 | 12625328 | Stupor | |
| 126253282 | 12625328 | Toxicity to various agents | |
| 126253282 | 12625328 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |